ClinConnect ClinConnect Logo
Search / Trial NCT06887608

The Effect of Partner-Assisted Rebozo Application in the Intrapartum Period on Birth Fear, Pain and Satisfaction

Launched by ISTANBUL UNIVERSITY - CERRAHPASA · Mar 16, 2025

Trial Information

Current as of April 22, 2025

Not yet recruiting

Keywords

Birth, Rebozo, Fear Of Birth, Birth Pain, Satisfaction

ClinConnect Summary

Childbirth is a challenging and life-changing experience for women that has emotional and physical effects. Every woman wants to remember her childbirth as a positive process, but the pain and suffering that accompanies this process can affect the perception of the pregnant woman. A long labor can increase complications for the baby and the mother. Despite all this, adapting to labor pain increases women's satisfaction with the labor process. For this, it is necessary to adopt methods that can reduce the duration and intensity of labor pain to a safe range and thus facilitate adaptation to ...

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • Being literate,
  • Knowing Turkish,
  • Being over 18 years of age,
  • Being primiparous,
  • Having a single fetus and cephalic presentation,
  • Being at term (37-42 weeks),
  • Not having risk factors during pregnancy (Preeclampsia, premature rupture of membranes, oligohydramnios and polyhydramnios, gestational diabetes, placental anomalies, intrauterine growth retardation, intrauterine dead fetus, fetal distress, macrosomic babies, etc.),
  • Being in the active phase of the first stage of labor,
  • Those who agree to participate in the research,
  • The spouse also agrees to participate in the research.
  • Exclusion Criteria:
  • Being multiparous,
  • Having multiple pregnancies,
  • Women with any chronic disease,
  • Women with a diagnosed psychiatric disease,
  • Pregnant women with spine and bone structure problems.

Trial Officials

DİLAN C Phd Candidate

Principal Investigator

Istanbul University - Cerrahpasa

About Istanbul University Cerrahpasa

Istanbul University - Cerrahpasa is a prestigious academic institution renowned for its commitment to advancing medical research and education. With a focus on innovative clinical trials, the university harnesses cutting-edge methodologies to address pressing health challenges. Its collaborative environment fosters interdisciplinary research, enabling the development of effective therapeutic strategies and enhancing patient care. The institution's dedication to ethical standards and patient safety underscores its reputation as a leader in clinical research within the region and beyond.

Locations

Zeyti̇nburnu, İ̇stanbul, Turkey

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported